ESLA
Estrella Immunopharma, Inc. - Common Stock (ESLA)
$53
About Estrella Immunopharma, Inc. - Common Stock (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.15
52 Week Low
$0.51
Market cap
23.0M
Dividend yield
-
Volume
6,013
Avg. volume
42,023
P/E ratio
-2.09
Estrella Immunopharma, Inc. - Common Stock News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.15
52 Week Low
$0.51
Market cap
23.0M
Dividend yield
-
Volume
6,013
Avg. volume
42,023
P/E ratio
-2.09